PMID- 20110857 OWN - NLM STAT- MEDLINE DCOM- 20100406 LR - 20100310 IS - 1534-6080 (Electronic) IS - 0041-1337 (Linking) VI - 89 IP - 5 DP - 2010 Mar 15 TI - Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. PG - 567-72 LID - 10.1097/TP.0b013e3181c69855 [doi] AB - BACKGROUND: Posttransplant non-Hodgkin lymphoma is a rare complication but associated with high mortality. The extent to which human leukocyte antigen (HLA) mismatching influences the rate of posttransplant lymphoma has not been clarified. METHODS: Data on lymphomas occurring in the first 3 years posttransplant were analyzed among first kidney transplants from deceased donors performed between 1985 and 2007 and reported to the Collaborative Transplant Study. RESULTS: Of 152,728 patients included, 593 non-Hodgkin lymphomas were diagnosed. Cox multivariate regression analysis showed that HLA-A mismatches had no influence on the rate of lymphoma. One and two HLA-DR mismatches were associated with a hazard ratio (HR) of 1.21 (95% confidence interval 1.00-1.45, P=0.047) and 1.56 (95% confidence interval 1.21-1.99, P<0.001), respectively. For lymphoma of the kidney and central nervous system, HRs for two HLA-DR mismatches were 2.29 (P=0.007) and 2.17 (P=0.029), respectively. Two HLA-B mismatches were also significantly associated with lymphoma in the kidney (HR 2.82, P=0.009). CONCLUSION: Mismatches at the HLA-DR locus are a significant risk factor for posttransplant non-Hodgkin lymphoma, particularly in the kidney and central nervous system, whereas two HLA-B mismatches increase the risk for the development of lymphoma of the kidney. FAU - Opelz, Gerhard AU - Opelz G AD - Department of Transplantation Immunology, University of Heidelberg, Im Neuenheimer Feld 305, D-61920 Heidelberg, Germany. gerhard.opelz@med.uni-heidelberg.de FAU - Dohler, Bernd AU - Dohler B LA - eng PT - Journal Article PL - United States TA - Transplantation JT - Transplantation JID - 0132144 RN - 0 (HLA Antigens) RN - 0 (HLA-DR Antigens) SB - IM MH - Adolescent MH - Adult MH - Demography MH - Female MH - HLA Antigens/*immunology MH - HLA-DR Antigens/immunology MH - Histocompatibility Testing/methods MH - Humans MH - Incidence MH - Kidney Transplantation/adverse effects/*immunology/pathology MH - Lymphoma, Non-Hodgkin/*epidemiology MH - Male MH - Middle Aged MH - Postoperative Complications/*epidemiology/pathology MH - Young Adult EDAT- 2010/01/30 06:00 MHDA- 2010/04/07 06:00 CRDT- 2010/01/30 06:00 PHST- 2010/01/30 06:00 [entrez] PHST- 2010/01/30 06:00 [pubmed] PHST- 2010/04/07 06:00 [medline] AID - 10.1097/TP.0b013e3181c69855 [doi] PST - ppublish SO - Transplantation. 2010 Mar 15;89(5):567-72. doi: 10.1097/TP.0b013e3181c69855.